Articles producció científica> Bioquímica i Biotecnologia

New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9

  • Datos identificativos

    Identificador: PC:2595
    Autores:
    Sánchez-López E, Ettcheto M, Egea MA, Espina M, Calpena AC, Folch J, Camins A, García ML.
    Resumen:
    DOI: 10.1016/j.nano.2016.12.003 URL: http://www.sciencedirect.com/science/article/pii/S1549963416302209 Filiació URV: SI Memòria
  • Otros:

    Autor según el artículo: Sánchez-López E, Ettcheto M, Egea MA, Espina M, Calpena AC, Folch J, Camins A, García ML.
    Departamento: Bioquímica i Biotecnologia
    Autor/es de la URV: FOLCH LOPEZ, JAUME
    Palabras clave: nanoparticles Alzheimer's disease
    Resumen: Dexibuprofen loaded pegylated poly(lactic-co-glycolic) nanospheres prepared by solvent diffusion method were designed to increase Dexibuprofen brain delivery reducing systemic side effects. Nanospheres exhibited a mean particle size around 200 nm (195.4 nm), monomodal population and negative surface charge. Drug loaded nanospheres showed a sustained release profile, allowing to modify the posology in vivo. Nanospheres were non-toxic neither in brain endothelial cells nor astrocytes and do not cause blood–brain barrier disruption. Nanospheres were able to partially cross the cells barrier and release the drug after co-culture in vitro experiments, increasing Dexibuprofen permeation coefficient. Behavioral tests performed in APPswe/PS1dE9 mice (mice model of familial Alzheimer's disease) showed that nanospheres reduce memory impairment more efficiently than the free drug. Developed nanospheres decrease brain inflammation leading to β-amyloid plaques reduction. According to these results, chronical oral Dexibuprofen pegylated poly(lactic-co-glycolic) nanosystems could constitute a suitable strategy for the prevention of neurodegeneration.
    Grupo de investigación: Farmacobiologia Cel.lular
    Áreas temáticas: Biochemistry and technology Bioquímica y tecnología Bioquímica i biotecnologia
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 1549-9634
    Fecha de alta del registro: 2017-03-07
    Página final: 1182
    Volumen de revista: 13
    Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
    Enlace a la fuente original: https://www.sciencedirect.com/science/article/abs/pii/S1549963416302209
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI del artículo: 10.1016/j.nano.2016.12.003
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2017
    Página inicial: 1171
    Tipo de publicación: Article Artículo Article
  • Palabras clave:

    Nanopartícules
    Alzheimer, Malaltia d' -- Prevenció
    nanoparticles
    Alzheimer's disease
    Biochemistry and technology
    Bioquímica y tecnología
    Bioquímica i biotecnologia
    1549-9634
  • Documentos:

  • Cerca a google

    Search to google scholar